Biliary lipids output is reduced after liver transplantation and tends to normalize thereafter. Cyclosporine A (CyA) is reported to interfere with the normal bile-restoring process after liver grafting, but data are inconclusive, in particular regarding the comparison with the other widely used calcineurin inhibitor tacrolimus (TCR). Furthermore, previous researches were conducted in patients taking multiple immunosuppressive therapies and with a short follow up. In this study we readdressed this issue by comparing biliary lipids in the first 3 months after liver transplant, in 20 patients randomized to receive immunosuppression with CyA or TCR monotherapy. Bile samples, harvested through a T-tube at days 1, 3, 7, 15, 30, 60 and 90 were assessed for cholesterol, phospholipids, and total and individual concentrations of bile acids (BA). Liver and kidney function tests were evaluated as well. We found no differences between CyA and TCR in biochemical findings or in total biliary BAs, cholesterol, and phospholipids. However, CyA-treated patients showed lower levels of glycochenodeoxycholic acid at day 15, compared to those treated with TCR (P < 0.04). This difference normalized thereafter, without any biochemical or clinical effect at 3-month follow up.

Baiocchi, L., Angelico, M., De Luca, L., Ombres, D., Anselmo, A., Telesca, C., et al. (2006). Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. TRANSPLANT INTERNATIONAL, 19(5), 389-395 [10.1111/j.1432-2277.2006.00296.x].

Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans

BAIOCCHI, LEONARDO;ANGELICO, MARIO;TISONE, GIUSEPPE
2006-01-01

Abstract

Biliary lipids output is reduced after liver transplantation and tends to normalize thereafter. Cyclosporine A (CyA) is reported to interfere with the normal bile-restoring process after liver grafting, but data are inconclusive, in particular regarding the comparison with the other widely used calcineurin inhibitor tacrolimus (TCR). Furthermore, previous researches were conducted in patients taking multiple immunosuppressive therapies and with a short follow up. In this study we readdressed this issue by comparing biliary lipids in the first 3 months after liver transplant, in 20 patients randomized to receive immunosuppression with CyA or TCR monotherapy. Bile samples, harvested through a T-tube at days 1, 3, 7, 15, 30, 60 and 90 were assessed for cholesterol, phospholipids, and total and individual concentrations of bile acids (BA). Liver and kidney function tests were evaluated as well. We found no differences between CyA and TCR in biochemical findings or in total biliary BAs, cholesterol, and phospholipids. However, CyA-treated patients showed lower levels of glycochenodeoxycholic acid at day 15, compared to those treated with TCR (P < 0.04). This difference normalized thereafter, without any biochemical or clinical effect at 3-month follow up.
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/12 - Gastroenterologia
Settore MED/18 - Chirurgia Generale
English
Con Impact Factor ISI
bile acid; calcineurin inhibitor; cholesterol; cyclosporin A; glycochenodeoxycholic acid; lipid; phospholipid; tacrolimus; adult; aged; article; clinical article; clinical trial; female; follow up; human; immunosuppressive treatment; kidney function test; lipid bile level; liver function test; liver graft; liver transplantation; male; monotherapy; postoperative period; priority journal; Age Factors; Aged; Bile; Chromatography, High Pressure Liquid; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lipids; Liver Transplantation; Male; Middle Aged; Sex Factors; Tacrolimus; Time Factors
Bile acids; Biliary lipids; Cyclosporine A; Liver transplantation; Tacrolimus
Baiocchi, L., Angelico, M., De Luca, L., Ombres, D., Anselmo, A., Telesca, C., et al. (2006). Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. TRANSPLANT INTERNATIONAL, 19(5), 389-395 [10.1111/j.1432-2277.2006.00296.x].
Baiocchi, L; Angelico, M; De Luca, L; Ombres, D; Anselmo, A; Telesca, C; Orlando, G; D'Andria, D; Tisone, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/57926
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 7
social impact